Telomerase: A target for cancer therapeutics

Jerry W. Shay, Woodring E. Wright

Research output: Contribution to journalReview articlepeer-review

296 Scopus citations


The continuous growth of advanced malignancies almost universally correlates with the reactivation of telomerase. While there is still a great deal of basic and applied research to be done, telomerase remains a very attractive novel target for cancer therapeutics. In this review, we will discuss the challenges and the pros and cons of the most promising antitelomerase approaches currently being investigated.

Original languageEnglish (US)
Pages (from-to)257-265
Number of pages9
JournalCancer Cell
Issue number4
StatePublished - Oct 2002

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research


Dive into the research topics of 'Telomerase: A target for cancer therapeutics'. Together they form a unique fingerprint.

Cite this